Spectrum Pharmaceuticals (SPPI) 10-Q2008 Q2 Quarterly report

Filed: 11 Aug 08, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: AU, bearing, bone, built, calendar, dislocation, dissolved, enacted, enactment, Fairly, fusilev, invasive, light, methotraxate, nongovernmental, Oversight, pace, partially, provision, recovered, remaining, rest, shift, shortly, stabilize, taxable, temporary, till

Removed: achieve, achievement, adjust, adverse, arising, authorization, automatically, base, computing, declared, demonstrated, detail, devote, distribution, diversified, Dr, effort, expanded, financed, goal, historically, individually, informed, initiate, initiation, issuance, July, Lenaz, list, nearer, obligating, occurring, offering, order, ordinary, President, prostate, renew, resolution, resulted, resulting, salary, seek, show, Shrotriya, solicitation, trading, twelve, underwriting, variety, written

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

SPPI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

Certification of Principal Executive Officer

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Spectrum Pharmaceuticals, Inc. (the “Company”) hereby certifies, to such officer’s knowledge, that:

(i) the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended June 30, 2008 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: August 11, 2008	/s/ RAJESH C. SHROTRIYA
	Rajesh C. Shrotriya
	Chairman, Chief Executive Officer and President